IBANDRONATE Spirig HC 150 mg compr mensuels 3 pce

7680631190047 CH-63119 M05BA06 07.99.0.

Reimbursement limitations:

BONVIVA

Pour le traitement de l'ostéoporose documentée.

IBANDRONATE Spirig HC 150 mg compr mensuels 3 pce
IBANDRONATE Spirig HC 150 mg compr mensuels 3 pce
IBANDRONATE Spirig HC 150 mg compr mensuels 3 pce
1 / 3
google

Details

Product number
6311901
CPT
-
Packaging group
3
Unit
Tablette(n)
Composition
acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Articles (1)

Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten
Filmtabletten
3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/09/2022
Patient information leaflet
Français
13/09/2022
Patient information leaflet
Italien
13/09/2022
Professional SmPC
Allemand
13/09/2022
Professional SmPC
Français
13/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 62.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/06/2013

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
63119
Drug name
Ibandronat Spirig HC Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Authorization category
Category C
Dispensation category
B
First authorization
26/03/2013
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONATE Spirig HC 150 mg compr mensuels 3 pce
Description (DE)
IBANDRONAT Spirig HC 150 mg Monatstabl 3 Stk
Market launch
26/03/2013
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original

Other packaging sizes

IBANDRONATE Spirig HC 150 mg compr mensuels
1 TABL
GTIN: 7680631190030
View